Evidence map›Paper›PMID 23929517›Full record

Trial reportJAMA ophthalmology2013

Differences in clinical outcomes in keratitis due to fungus and bacteria.

N Venkatesh Prajna, Muthiah Srinivasan, Prajna Lalitha, Tiruvengada Krishnan, Revathi Rajaraman, Meenakshi Ravindran, Jeena Mascarenhas, Catherine E Oldenburg, Kathryn J Ray, Stephen D McLeod and 2 more

Open access · greenAbstract readComparative StudyLetterRandomized Controlled Trial
In one paragraph

Trial report in JAMA ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Medical interventions for fungal keratitis.The Cochrane database of systematic reviews · 2015
    Pooled it
  3. Trial
  4. Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2019
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Update on the management of fungal keratitis.International ophthalmology · 2021
    Review
  20. First report of a new corneal pathogen: Phaeoacremonium parasiticum.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

N Venkatesh Prajna
Muthiah Srinivasan
Prajna Lalitha
Tiruvengada Krishnan
Revathi Rajaraman
Meenakshi Ravindran
Jeena Mascarenhas
Catherine E Oldenburg
Kathryn J Ray
Stephen D McLeod
Nisha R Acharya
Thomas M Lietman
Aravind Eye Hospital · INUniversity of California, San Francisco · USSan Francisco Foundation · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 1985 to 2024
$16.8M
The Steroids for Cornea Ulcers TrialU10EY015114 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M · 2005 to 2009
$2.4M
Predicting and Improving Clinical Outcomes for Bacterial KeratitisK23EY017897 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ACHARYA, NISHA · 2007 to 2011
$1.1M
NEI NIH HHS EY02162NEI NIH HHS K23 EY017897NEI NIH HHS K23EY017897NEI NIH HHS P30 EY002162NEI NIH HHS U10 EY015114
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsBacteriaCorneal PerforationCorneal UlcerEye Infections, BacterialEye Infections, FungalFungiHumansTreatment OutcomeVisual AcuityAnti-Bacterial AgentsAntifungal Agents

Identifiers

PMID23929517
PMCPMC3845453
OpenAlexW2021019212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.